P10.21 2-hydroxyglutarate as a biomarker for IDH mutation in low grade gliomas

Glioma patients continue to carry a very poor prognosis despite maximal therapy. Several genetic alterations are linked with better survival outcome in glioma patients, including mutations in isocitrate dehydrogenase 1 and 2 (IDH1/2). The product of IDH mutation is the chemical 2-hydroxyglutarate (2...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Neuro Oncol
Main Authors: Nejad, R., Sim, H., Aldape, K., Mason, W., Bernstein, M., Gentili, F., Kalia, S., Tung, T., Chen, E., Zadeh, G.
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2017
Fag:
POSTER PRESENTATIONS
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5463979/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.339
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker